Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-2179.34%
operating margin TTM
-2270.68%
revenue TTM
2.93 Million
revenue per share TTM
0.08$
valuation ratios | |
|---|---|
| pe ratio | -2.76 |
| peg ratio | 1.44 |
| price to book ratio | 3.44 |
| price to sales ratio | 60.75 |
| enterprise value multiple | -3.09 |
| price fair value | 3.44 |
profitability ratios | |
|---|---|
| gross profit margin | 88.55% |
| operating profit margin | -2270.68% |
| pretax profit margin | -2179.34% |
| net profit margin | -2179.34% |
| return on assets | -76.59% |
| return on equity | -107.04% |
| return on capital employed | -101.7% |
liquidity ratio | |
|---|---|
| current ratio | 4.23 |
| quick ratio | 4.21 |
| cash ratio | 1.58 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 281.88 |
| operating cycle | 297.74 |
| days of payables outstanding | 5,689.42 |
| cash conversion cycle | -5,391.68 |
| receivables turnover | 23.02 |
| payables turnover | 0.06 |
| inventory turnover | 1.29 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.04 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.04 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -26.11 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.28 |
| cash per share | 1.78 |
| operating cash flow per share | -1.28 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -26.11 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -266.63 |
Frequently Asked Questions
When was the last time Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) reported earnings?
Orchestra BioMed Holdings, Inc. (OBIO) published its most recent earnings results on 12-11-2024.
What is Orchestra BioMed Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO)'s trailing twelve months ROE is -107.04%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Orchestra BioMed Holdings, Inc. (OBIO) currently has a ROA of -76.59%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did OBIO's net profit margin stand at?
OBIO reported a profit margin of -2179.34% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is OBIO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.23 in the most recent quarter. The quick ratio stood at 4.21, with a Debt/Eq ratio of 0.04.